- Home
- OPI vs COYA Comparison
OPI vs COYA Comparison
Compare OPI & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- COYA
- Stock Information
- Founded
- OPI 2009
- COYA 2020
- Country
- OPI United States
- COYA United States
- Employees
- OPI N/A
- COYA N/A
- Industry
- OPI Real Estate Investment Trusts
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- OPI Real Estate
- COYA Health Care
- Exchange
- OPI Nasdaq
- COYA Nasdaq
- Market Cap
- OPI 105.1M
- COYA 104.3M
- IPO Year
- OPI 2009
- COYA 2022
- Fundamental
- Price
- OPI $1.02
- COYA $5.24
- Analyst Decision
- OPI Buy
- COYA Strong Buy
- Analyst Count
- OPI 2
- COYA 4
- Target Price
- OPI $4.30
- COYA $16.25
- AVG Volume (30 Days)
- OPI 1.5M
- COYA 78.0K
- Earning Date
- OPI 02-13-2025
- COYA 11-06-2024
- Dividend Yield
- OPI 3.92%
- COYA N/A
- EPS Growth
- OPI N/A
- COYA N/A
- EPS
- OPI N/A
- COYA N/A
- Revenue
- OPI $517,514,000.00
- COYA $9,554,315.00
- Revenue This Year
- OPI N/A
- COYA N/A
- Revenue Next Year
- OPI N/A
- COYA $87.80
- P/E Ratio
- OPI N/A
- COYA N/A
- Revenue Growth
- OPI N/A
- COYA N/A
- 52 Week Low
- OPI $1.02
- COYA $4.75
- 52 Week High
- OPI $7.53
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- OPI 29.66
- COYA 32.54
- Support Level
- OPI $1.32
- COYA $5.07
- Resistance Level
- OPI $1.99
- COYA $5.96
- Average True Range (ATR)
- OPI 0.10
- COYA 0.38
- MACD
- OPI -0.03
- COYA -0.06
- Stochastic Oscillator
- OPI 0.00
- COYA 12.45
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its largest tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.